Utama › Gangguan Depresi Major › Connecticut › North Stamford
Kajian klinikal Gangguan Depresi Major di North Stamford, CT
6 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar North Stamford (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- Bioscience Research LLC, Mount Kisco · 11 mi jauh
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Mengambil pesertaFasa 3
- Bioscience Research LLC, Mount Kisco · 11 mi jauh
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Mengambil pesertaFasa 3
- Bioscience Research, LLC, Mount Kisco · 11 mi jauh
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Mount Kisco · 11 mi jauh
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Mount Kisco · 11 mi jauh
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Mengambil pesertaFasa 4
- Clinical Research Site, Mount Kisco · 11 mi jauh
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY36 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Chicago, IL17 kajian
- Tampa, FL17 kajian
- San Diego, CA16 kajian
- Houston, TX16 kajian
- Little Rock, AR14 kajian
- Austin, TX13 kajian
Kajian lain di North Stamford
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.